Last reviewed · How we verify

NCT04627194

Characteristics of COVID-19 Patients in Kazakhstan in Early 2020

Status unknown Last updated 13 November 2020
What this trial tests

trial in Covid19 in 1,000 participants. Status unknown.

Timeline
20 February 2020
Primary endpoint
30 April 2020
1 December 2020

Quick facts

Lead sponsorSemey State Medical University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date20 February 2020
Primary completion30 April 2020
Estimated completion1 December 2020
Sites1 location across Kazakhstan

Conditions studied

Sponsor

Semey State Medical University

Who can join

0 and older, any sex, with Covid19 or Pneumonia, Viral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the epidemiological and clinical features of patients diagnosed with COVID-19 in Kazakhstan at the onset of the pandemic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Semey State Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04627194.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing